Cargando…
Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
Ovarian cancer remains the most fatal gynecologic malignancy worldwide due to delayed diagnosis as well as recurrence and drug resistance. Thus, the development of new tumor-related molecules with high sensitivity and specificity to replace or supplement existing tools is urgently needed. Cancer-tes...
Autores principales: | Xie, Kaipeng, Fu, Chenyang, Wang, Suli, Xu, Hanzi, Liu, Siyu, Shao, Yang, Gong, Zhen, Wu, Xiaoli, Xu, Bo, Han, Jing, Xu, Juan, Xu, Pengfei, Jia, Xuemei, Wu, Jiangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318940/ https://www.ncbi.nlm.nih.gov/pubmed/30609934 http://dx.doi.org/10.1186/s13048-018-0475-z |
Ejemplares similares
-
The Cancer-Testis Long Non-coding RNA PCAT6 Facilitates the Malignant Phenotype of Ovarian Cancer by Sponging miR-143-3p
por: Tan, Xiaofang, et al.
Publicado: (2021) -
OPCML Methylation and the Risk of Ovarian Cancer: A Meta and Bioinformatics Analysis
por: Shao, Yang, et al.
Publicado: (2021) -
Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer
por: Nin, Dawn Sijin, et al.
Publicado: (2023) -
Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer
por: Vlasenkova, Ramilia, et al.
Publicado: (2023) -
Infrequent Expression of the Cancer-Testis Antigen, PASD1, in Ovarian Cancer
por: Khan, Ghazala, et al.
Publicado: (2015)